
Based on the good results of experimental transplantation in animal models of multiple sclerosis and of other zzso diseases, we have treated 24 patients suffering from chronic progressive multiple sclerosis with high-dose chemotherapy zzso zzso followed by zzso blood stem cell rescue and zzso zzso Blood stem cells were zzso with zzso at zzso and zzso (or zzso zzso In 9 cases, additional zzso zzso of the graft was zzso Here we update previously published results of this novel treatment, mainly with regard to clinical zzso as the median follow-up time has reached 40 months zzso zzso zzso were the principal toxicity early after the zzso with death of a patient from zzso 65 days post stem cell zzso No serious late events occurred apart from a case of zzso zzso that developed 11 months after transplant in a patient who had received a zzso zzso zzso zzso and transient zzso was observed in 10 patients zzso most probably associated with fever and zzso zzso patients zzso zzso responded to the treatment, zzso they were improved or zzso while five patients zzso of which 4 had primary progressive zzso Of those improved or zzso zzso 9 patients have maintained stable condition whereas 9 developed relapses or they slowly resumed zzso although their disability scores have not gotten worse than they were before zzso The probability of zzso survival zzso to entry zzso at 3 years is zzso for patients with secondary progressive disease and zzso for the primary progressive zzso zzso zzso did not seem to yield better results except for a delay in progression or in zzso after zzso These results appear better than those achieved by any other treatment of progressive multiple zzso including zzso but they need to be confirmed by other open or controlled studies in view of the well-known difficulty of judging zzso the effect of a treatment in patients with this zzso 

